Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer.
about
MIIP accelerates epidermal growth factor receptor protein turnover and attenuates proliferation in non-small cell lung cancer.Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer.A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo.FLNa negatively regulated proliferation and metastasis in lung adenocarcinoma A549 cells via suppression of EGFR.Unveiling NIR Aza-Boron-Dipyrromethene (BODIPY) Dyes as Raman Probes: Surface-Enhanced Raman Scattering (SERS)-Guided Selective Detection and Imaging of Human Cancer Cells.MICAL2 promotes breast cancer cell migration by maintaining epidermal growth factor receptor (EGFR) stability and EGFR/P38 signalling activation.Antitumor activity of nimotuzumab in combination with cisplatin in lung cancer cell line A549 in vitro.Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma.
P2860
Q36962526-A0098C45-AA8E-47FA-BDBC-E4CABBF75274Q37714120-11CFFAAA-AB40-403B-9790-D6EB59920361Q38717131-0158847B-B394-4472-92F9-5EB17DB09684Q47260594-7CAFD39B-62D4-4CFC-8155-FBE511D555BEQ50506173-E727D97C-427A-4433-BDF8-9B85D95CE1B9Q50884256-37E21C1E-3093-44C3-99DD-682ABAF963F9Q52725862-EE256737-01A2-4EA9-8D95-A8B7E6BAB4FFQ55460041-5334576C-F0EA-4DF7-910B-8B21E8A0FC60
P2860
Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Overexpression of wildtype EGF ...... in non-small cell lung cancer.
@en
type
label
Overexpression of wildtype EGF ...... in non-small cell lung cancer.
@en
prefLabel
Overexpression of wildtype EGF ...... in non-small cell lung cancer.
@en
P2093
P2860
P356
P1433
P1476
Overexpression of wildtype EGF ...... in non-small cell lung cancer
@en
P2093
Aiqun Zhang
Caicun Zhou
Dengfeng Cao
Lixin Zhou
Naiqing Xu
P2860
P304
P356
10.18632/ONCOTARGET.6461
P407
P577
2016-01-01T00:00:00Z